Where the category stands in May 2026 — what's available, who to trust, what costs what. 22-min read, medically reviewed.
Read the guideAn independent overview of the compounded-GLP-1 telehealth market and the providers we cover — market size, what the FDA changed, and an honest read on each.
View the provider overviewOverview & reviewsPrimers for newcomers and deep dives for the curious. The foundation articles are published; more are in the pipeline.
View all Learn articlesWhat compounded and branded semaglutide and tirzepatide actually cost, from each provider's own published pricing.
David Bonfa is co-founder of CRE8 Pharmacy, a PCAB-accredited 503A compounding pharmacy in Florida, and president of 3AD Consulting Group, which advises compounding pharmacies and wellness clinics. He has roughly 25 years in the pharmaceutical-compounding and functional-medicine industry. He advises PeptideWellness on how compounded medications are prepared, handled, and quality-controlled. He is not a licensed clinician and does not perform medical review.
Compounding & Industry Advisor Contributor to PeptideWellness editorial coverage. LinkedIn.
David Bonfa is a co-founder of CRE8 Pharmacy, a compounding pharmacy, and president of 3AD Consulting Group, which advises pharmacies and clinics — businesses in the field PeptideWellness covers.
Every contributor works to the standards in our editorial policy, and clinical content is reviewed per our medical review process. How we source and verify is in our methodology.
Editorial note: this site is for informational purposes and does not constitute medical advice. Always consult a licensed healthcare provider familiar with your medical history.